Early research (Phase 1)Study completedNCT00004260What this trial is testingInterleukin-12 Plus Rituximab in Treating Patients With Non-Hodgkin's LymphomaWho this might be right forLymphoma Mayo Clinic
Early research (Phase 1)Study completedNCT00003962What this trial is testingInterleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic CancerWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Not applicableWithdrawnNCT00499668What this trial is testingAprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With CancerWho this might be right forMyeloproliferative DisordersLeukemiaLymphoma+5 more Vanderbilt-Ingram Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT00281879What this trial is testingDonor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more OHSU Knight Cancer Institute 200
Testing effectiveness (Phase 2)Study completedNCT00004197What this trial is testingVaccine Therapy Plus Sargramostim Following Chemotherapy in Previously Untreated Aggressive Non-Hodgkin's LymphomaWho this might be right forLymphoma University of Nebraska
Not applicableStudy completedNCT00003863What this trial is testingDiagnostic Study of Patients With Aggressive Non-Hodgkin's LymphomaWho this might be right forLymphoma Alliance for Clinical Trials in Oncology 391
Early research (Phase 1)Study completedNCT00243087What this trial is testingInvestigation of Safety, Tolerability and Maximum Tolerated Dose (MTD) of BI 2536 in Patients With Recurrent Advanced Aggressive Non-Hodgkin's Lymphoma (NHL)Who this might be right forLymphoma Boehringer Ingelheim 41
Not applicableStudy completedNCT00398372What this trial is testingClinical and Pathologic Studies in Non-Hodgkin's Lymphoma Patients Receiving Antibody TreatmentWho this might be right forLymphoma, Non-HodgkinLymphomas: Non-HodgkinLymphomas: Non-Hodgkin Cutaneous Lymphoma+6 more Stanford University 500
Early research (Phase 1)Ended earlyNCT03151057What this trial is testingIdelalisib Post Allogeneic Hematopoietic Stem Cell Transplant (HSCT) in B Cell Derived MalignanciesWho this might be right forB Cells-TumorsB Cell Chronic Lymphocytic LeukemiaFollicular Lymphoma+2 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 16
Early research (Phase 1)Study completedNCT00019019What this trial is testingCarboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory LymphomasWho this might be right forBrain and Central Nervous System TumorsBreast CancerKidney Cancer+6 more National Institutes of Health Clinical Center (CC) 70
Early research (Phase 1)Study completedNCT00047164What this trial is testingMonoclonal Antibody Therapy in Treating Patients With Lymphoma or Colon Cancer That Has Not Responded to Vaccine TherapyWho this might be right forLymphoma National Institutes of Health Clinical Center (CC) 89
Not applicableStudy completedNCT00521430What this trial is testingDonor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other DiseaseWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+3 more Asan Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT00703664What this trial is testingBortezomib and Vorinostat in Treating Patients With Recurrent Mantle Cell Lymphoma or Recurrent and/or Refractory Diffuse Large B-Cell LymphomaWho this might be right forRecurrent Mantle Cell LymphomaRecurrent Non-Hodgkin Lymphoma National Cancer Institute (NCI) 65
Early research (Phase 1)Looking for participantsNCT04830137What this trial is testingNX-2127 in Adults With Relapsed/Refractory B-cell MalignanciesWho this might be right forChronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL)Waldenstrom Macroglobulinemia (WM)+5 more Nurix Therapeutics, Inc. 248
Not applicableLooking for participantsNCT06339255What this trial is testingItalian Observational Study on CAR-T Therapy for LymphomaWho this might be right forDiffuse Low Grade B-Cell LymphomaPrimary Mediastinal Large B-cell Lymphoma (PMBCL)Mantle Cell Lymphoma+1 more Paolo Corradini 5,300
Not applicableWithdrawnNCT00093678What this trial is testingCelecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced CancerWho this might be right forCachexiaLymphomaMelanoma (Skin)+4 more Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Study completedNCT00003874What this trial is testingMonoclonal Antibody Therapy in Treating Patients With Lymphoma or LeukemiaWho this might be right forLeukemiaLymphoma Fred Hutchinson Cancer Center
Large-scale testing (Phase 3)Ended earlyNCT00003056What this trial is testingPrevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell TransplantationWho this might be right forLeukemiaLymphomaGraft Versus Host Disease Baxalta now part of Shire 105
Testing effectiveness (Phase 2)Study completedNCT00807495What this trial is testingStudy of Alisertib (MLN8237) in Adults With Aggressive Non-Hodgkin's LymphomaWho this might be right forDiffuse Large B-cell LymphomaMantle Cell LymphomaBurkitt's Lymphoma+2 more Millennium Pharmaceuticals, Inc. 48
Early research (Phase 1)Study completedNCT04279405What this trial is testingA Phase Ib Study of YY-20394 in Participants With B-cell Hematologic MalignanciesWho this might be right forSmall Lymphocytic LymphomaLymphoplasmacytic LymphomaMarginal Zone Lymphoma+2 more Shanghai YingLi Pharmaceutical Co. Ltd. 43